These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 34983356)
1. Metainflammation in COVID-19. Bakhtiari M; Asadipooya K Endocr Metab Immune Disord Drug Targets; 2022; 22(12):1154-1166. PubMed ID: 34983356 [TBL] [Abstract][Full Text] [Related]
2. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart. Liu H; Gai S; Wang X; Zeng J; Sun C; Zhao Y; Zheng Z Cardiovasc Res; 2020 Aug; 116(10):1733-1741. PubMed ID: 32638018 [TBL] [Abstract][Full Text] [Related]
4. COVID-19: is there a link between the course of infection and pharmacological agents in diabetes? Filardi T; Morano S J Endocrinol Invest; 2020 Aug; 43(8):1053-1060. PubMed ID: 32495299 [TBL] [Abstract][Full Text] [Related]
5. Host-Cell Surface Binding Targets in SARS-CoV-2 for Drug Design. Maleksabet H; Rezaee E; Tabatabai SA Curr Pharm Des; 2022; 28(45):3583-3591. PubMed ID: 36420875 [TBL] [Abstract][Full Text] [Related]
6. COVID-19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity? Bassendine MF; Bridge SH; McCaughan GW; Gorrell MD J Diabetes; 2020 Sep; 12(9):649-658. PubMed ID: 32394639 [TBL] [Abstract][Full Text] [Related]
7. ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2. Sharma RK; Stevens BR; Obukhov AG; Grant MB; Oudit GY; Li Q; Richards EM; Pepine CJ; Raizada MK Hypertension; 2020 Sep; 76(3):651-661. PubMed ID: 32783758 [TBL] [Abstract][Full Text] [Related]
8. Interactions of renin-angiotensin system and COVID-19: the importance of daily rhythms in ACE2, ADAM17 and TMPRSS2 expression. Zlacká J; Stebelová K; Zeman M; Herichová I Physiol Res; 2021 Dec; 70(S2):S177-S194. PubMed ID: 34913351 [TBL] [Abstract][Full Text] [Related]
9. Age and gender differences in ACE2 and TMPRSS2 expressions in oral epithelial cells. Peng J; Sun J; Zhao J; Deng X; Guo F; Chen L J Transl Med; 2021 Aug; 19(1):358. PubMed ID: 34412632 [TBL] [Abstract][Full Text] [Related]
10. Term Human Placental Trophoblasts Express SARS-CoV-2 Entry Factors ACE2, TMPRSS2, and Furin. Ouyang Y; Bagalkot T; Fitzgerald W; Sadovsky E; Chu T; Martínez-Marchal A; Brieño-Enríquez M; Su EJ; Margolis L; Sorkin A; Sadovsky Y mSphere; 2021 Apr; 6(2):. PubMed ID: 33853873 [TBL] [Abstract][Full Text] [Related]
11. Effect of common medications on the expression of SARS-CoV-2 entry receptors in liver tissue. Saheb Sharif-Askari N; Saheb Sharif-Askari F; Mdkhana B; Al Heialy S; Ratemi E; Alghamdi M; Abusnana S; Kashour T; Hamid Q; Halwani R Arch Toxicol; 2020 Dec; 94(12):4037-4041. PubMed ID: 32808185 [TBL] [Abstract][Full Text] [Related]
12. A Newly Engineered A549 Cell Line Expressing ACE2 and TMPRSS2 Is Highly Permissive to SARS-CoV-2, Including the Delta and Omicron Variants. Chang CW; Parsi KM; Somasundaran M; Vanderleeden E; Liu P; Cruz J; Cousineau A; Finberg RW; Kurt-Jones EA Viruses; 2022 Jun; 14(7):. PubMed ID: 35891350 [TBL] [Abstract][Full Text] [Related]
13. Epipharyngeal Abrasive Therapy Down-regulates the Expression of SARS-CoV-2 Entry Factors ACE2 and TMPRSS2. Nishi K; Yoshimoto S; Nishi S; Tsunoda T; Ohno J; Yoshimura M; Hiromatsu K; Yamano T In Vivo; 2022; 36(1):371-374. PubMed ID: 34972736 [TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients. Dai YJ; Zhang WN; Wang WD; He SY; Liang CC; Wang DW Int J Biol Sci; 2020; 16(15):3028-3036. PubMed ID: 33061814 [TBL] [Abstract][Full Text] [Related]
15. Regulation of SARS CoV-2 host factors in the kidney and heart in rats with 5/6 nephrectomy-effects of salt, ARB, DPP4 inhibitor and SGLT2 blocker. Xiong Y; Delic D; Zeng S; Chen X; Chu C; Hasan AA; Krämer BK; Klein T; Yin L; Hocher B BMC Nephrol; 2022 Mar; 23(1):117. PubMed ID: 35331159 [TBL] [Abstract][Full Text] [Related]
16. Importance of ACE2 for SARS-CoV-2 Infection of Kidney Cells. Kroll MK; Schloer S; Candan P; Korthals N; Wenzel C; Ihle H; Gilhaus K; Liedtke KR; Schöfbänker M; Surmann B; Schröter R; Neugebauer U; Mall G; Oswald S; Ludwig S; Rescher U; Vollenbröker B; Ciarimboli G Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979408 [TBL] [Abstract][Full Text] [Related]
17. Nasopharyngeal Expression of Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 in Children within SARS-CoV-2-Infected Family Clusters. Hasan MR; Ahmad MN; Dargham SR; Zayed H; Al Hashemi A; Ngwabi N; Perez Lopez A; Dobson S; Abu Raddad LJ; Tang P Microbiol Spectr; 2021 Dec; 9(3):e0078321. PubMed ID: 34730438 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme 2 and transmembrane protease serine 2 in female and male patients with end-stage kidney disease. Arefin S; Hernandez L; Ward LJ; Schwarz A; ; Barany P; Stenvinkel P; Kublickiene K Eur J Clin Invest; 2022 Aug; 52(8):e13786. PubMed ID: 35366343 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical Study of SARS-CoV-2 Viral Entry Factors in the Cornea and Ocular Surface. Roehrich H; Yuan C; Hou JH Cornea; 2020 Dec; 39(12):1556-1562. PubMed ID: 32826650 [TBL] [Abstract][Full Text] [Related]
20. Hypercapnia increases ACE2 expression and pseudo-SARS-CoV-2 entry in bronchial epithelial cells by augmenting cellular cholesterol. Chen F; Matsuda A; Budinger GRS; Sporn PHS; Casalino-Matsuda SM Front Immunol; 2023; 14():1251120. PubMed ID: 37901225 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]